CAIHL read · Jun 10, 2026

← Back to Jun 10, 2026 scan

Doctors could face legal action over AI errors in NHS care

What CAIHL does

Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.

The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.

This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.

How this item reads through CAIHL

Primary user

clinician

Clinicians or care teams are the primary users. Patients are affected downstream.

Hosting

institutional

Hosted inside a health system, insurer, or large employer. Access controlled by the institution.

Interests

mixed

Multiple stakeholder interests in tension; the alignment is not stable.

Agency

constraining

Channels patients toward predetermined pathways or substitutes for patient capabilities.

One-sentence synthesis

Liability landing on clinicians for AI errors with vendor accountability unresolved; constraining patient agency through the protection gap.

How this item appeared in the daily scan

Editor's note: If the clinician is the legal endpoint and the vendor is upstream of disclosure, the patient is downstream of both — left to compare a clinician's decision to a model the clinician can't inspect either.

Summary: Computing UK: Reporting on emerging UK legal framework that would hold individual NHS doctors personally liable for downstream patient harm from AI tools they used — vendor liability remains unresolved.

Read the original source →

methodology

Limitations

CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.